|
Volumn 29, Issue 4, 2002, Pages 707-716
|
Effects of FTY720 in MRL-lpr/lpr mice: Therapeutic potential in systemic lupus erythematosus
a a a a a a a a a a a |
Author keywords
Apoptosis; FTY720; Lupus; Therapy
|
Indexed keywords
DNA ANTIBODY;
DOUBLE STRANDED DNA;
FINGOLIMOD;
IMMUNOGLOBULIN G;
INTERLEUKIN 2;
MEROCYANINE;
METHYLPREDNISOLONE;
PROPIDIUM IODIDE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
APOPTOSIS;
ARTICLE;
AUTOIMMUNE DISEASE;
CONTROLLED STUDY;
CYTOKINE RELEASE;
DRUG EFFECT;
DRUG EFFICACY;
FEMALE;
GENETIC PREDISPOSITION;
IMMUNOSUPPRESSIVE TREATMENT;
LIFESPAN;
LYMPHOCYTE PROLIFERATION;
LYMPHOID CELL;
MOUSE STRAIN;
NONHUMAN;
PHENOTYPE;
PRIORITY JOURNAL;
SURVIVAL RATE;
SYSTEMIC LUPUS ERYTHEMATOSUS;
ADMINISTRATION, ORAL;
ANIMALS;
ANTIBODIES, ANTINUCLEAR;
ANTIGEN-ANTIBODY COMPLEX;
APOPTOSIS;
BONE MARROW CELLS;
CELLS, CULTURED;
DISEASE MODELS, ANIMAL;
DNA;
FEMALE;
FLOW CYTOMETRY;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
INTERLEUKIN-2;
KIDNEY GLOMERULUS;
LONGEVITY;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
LYMPHOID TISSUE;
METHYLPREDNISOLONE;
MICE;
MICE, INBRED BALB C;
MICE, INBRED MRL LPR;
PROPYLENE GLYCOLS;
SPHINGOSINE;
T-LYMPHOCYTES;
|
EID: 0036228891
PISSN: 0315162X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (119)
|
References (48)
|